Hazlett, Burt & Watson’s Eli Lilly LLY Stock Holding History

Hazlett, Burt & Watson’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.24M	Buy	2,426 +53	+2%	+$53.7K	0.7%	32
2025 Q4	$2.55M	Buy	2,373 +271	+13%	+$259K	0.81%	24
2025 Q3	$1.61M	Buy	2,102 +262	+14%	+$195K	0.57%	41
2025 Q2	$1.43M	Buy	1,840 +316	+21%	+$246K	0.59%	42
2025 Q1	$1.26M	Buy	1,524 +26	+2%	+$21.6K	0.57%	46
2024 Q4	$1.16M	Buy	1,498 +40	+3%	+$33.1K	0.51%	47
2024 Q3	$1.29M	Buy	1,458 +109	+8%	+$98K	0.59%	36
2024 Q2	$1.23M	Buy	1,349 +58	+4%	+$46.4K	0.63%	34
2024 Q1	$1M	Buy	1,291 +85	+7%	+$60.5K	0.6%	34
2023 Q4	$703K	Buy	1,206 +427	+55%	+$249K	0.47%	44
2023 Q3	$419K	Buy	779 +159	+26%	+$81.9K	0.31%	67
2023 Q2	$290K	Buy	620 +269	+77%	+$113K	0.22%	96
2023 Q1	$121K	Buy	351 +21	+6%	+$7.08K	0.1%	175
2022 Q4	$121K	Buy	330 +1	+0.3%	+$355	0.11%	168
2022 Q3	$107K	Hold	329	–	–	0.1%	172
2022 Q2	$107K	Buy	329 +1	+0.3%	+$300	0.1%	189
2022 Q1	$94K	Buy	+328	New	+$84.4K	0.07%	217

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Hazlett, Burt & Watson's LLY Position: Q1 2026 in Review

Hazlett, Burt & Watson increased its Eli Lilly (LLY) stake by 2.2% in Q1 2026, buying an estimated $53.7K and bringing the position to 2,426 shares worth $2.24M. The position accounts for 0.7% of the portfolio, ranked #32.

Hazlett, Burt & Watson first reported a position in LLY in Q1 2022 and has held it in 17 quarters since. The position peaked at $2.55M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Hazlett, Burt & Watson held 2,426 shares of Eli Lilly worth $2.24M as of Q1 2026.
Hazlett, Burt & Watson bought 53 Eli Lilly shares in Q1 2026, an estimated $53.7K.
Eli Lilly made up 0.7% of Hazlett, Burt & Watson's portfolio in Q1 2026, its #32 holding.
Hazlett, Burt & Watson first reported a position in Eli Lilly in Q1 2022 and has held it in 17 quarters since.
Hazlett, Burt & Watson's Eli Lilly position peaked at $2.55M in Q4 2025.
4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q1 2026, filed 14 May 2026.